Qingyan Yuan

449 total citations
8 papers, 384 citations indexed

About

Qingyan Yuan is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Qingyan Yuan has authored 8 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Genetics and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Qingyan Yuan's work include Fibroblast Growth Factor Research (7 papers), Kruppel-like factors research (7 papers) and Epigenetics and DNA Methylation (4 papers). Qingyan Yuan is often cited by papers focused on Fibroblast Growth Factor Research (7 papers), Kruppel-like factors research (7 papers) and Epigenetics and DNA Methylation (4 papers). Qingyan Yuan collaborates with scholars based in China and Iraq. Qingyan Yuan's co-authors include Guiping Ren, Deshan Li, Wenfei Wang, Yaonan Liu, Siming Li, Fuliang Bai, Guiyou Tian, Yin-Hang Yu, Tong Zhang and Susu Qu and has published in prestigious journals such as Toxicology and Applied Pharmacology, Pharmacology Biochemistry and Behavior and Digestive Diseases and Sciences.

In The Last Decade

Qingyan Yuan

8 papers receiving 377 citations

Peers

Qingyan Yuan

MB

EPIDE

PHYSI

CMN

SURGE

Estel Solsona‐Vilarrasa Spain

Masaomi Tajimi Japan

Songping Yu China

Dahee Choi South Korea

Doris Kaltenecker Austria

Jeremy Johnson United States

Xianglan Quan South Korea

Kurt Jungermann Germany

Dongming Hou China

Elizabeth Moran United States

Estel Solsona‐Vilarrasa Spain

Qingyan Yuan

167 ×0.7

MB

131 ×2.2

EPIDE

82 ×1.5

PHYSI

22 ×0.4

CMN

51 ×1.4

SURGE

Citations per year, relative to Qingyan Yuan Qingyan Yuan (= 1×) peers Estel Solsona‐Vilarrasa

Countries citing papers authored by Qingyan Yuan

Since Specialization

Citations

This map shows the geographic impact of Qingyan Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyan Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyan Yuan more than expected).

Fields of papers citing papers by Qingyan Yuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyan Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyan Yuan. The network helps show where Qingyan Yuan may publish in the future.

Co-authorship network of co-authors of Qingyan Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyan Yuan. A scholar is included among the top collaborators of Qingyan Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyan Yuan. Qingyan Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Guo, Xiaochen, Xiangxiang Wang, Qingyan Yuan, et al.. (2019). Evaluation of a cell model expressing βKlotho for screening FGF21 analogues. Cytotechnology. 71(5). 1033–1041. 1 indexed citations

2.

Yu, Yin-Hang, Fuliang Bai, Wenfei Wang, et al.. (2015). Fibroblast growth factor 21 protects mouse brain against d-galactose induced aging via suppression of oxidative stress response and advanced glycation end products formation. Pharmacology Biochemistry and Behavior. 133. 122–131. 100 indexed citations

3.

Xu, Pengfei, Yingjie Zhang, Yunye Liu, et al.. (2015). Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways. Toxicology and Applied Pharmacology. 290. 43–53. 75 indexed citations

4.

Xu, Pengfei, Yingjie Zhang, Wenfei Wang, et al.. (2015). Long-Term Administration of Fibroblast Growth Factor 21 Prevents Chemically-Induced Hepatocarcinogenesis in Mice. Digestive Diseases and Sciences. 60(10). 3032–3043. 15 indexed citations

5.

Yu, Yin-Hang, Siming Li, Yaonan Liu, et al.. (2015). Fibroblast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway. International Immunopharmacology. 25(1). 74–82. 66 indexed citations

6.

Yu, Yin-Hang, Fuliang Bai, Yaonan Liu, et al.. (2015). Fibroblast growth factor (FGF21) protects mouse liver against d-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K/Akt pathways. Molecular and Cellular Biochemistry. 403(1-2). 287–299. 88 indexed citations

7.

Yu, Dan, Xianlong Ye, Qiang Wu, et al.. (2015). Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway. Endocrine. 52(3). 527–540. 15 indexed citations

8.

Xu, Pengfei, Yingjie Zhang, Qingyan Yuan, et al.. (2014). Long-acting hypoglycemic effects of PEGylated FGF21 and insulin glargine in mice with type 1 diabetes. Journal of Diabetes and its Complications. 29(1). 5–12. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact